AXIS Corporate Bond Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

AXIS Corporate Bond Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

AXIS Corporate Bond Fund - Direct (G)

5.82%

stock2

Nippon India Pharma Fund - Direct (G)

7.4%

Loading chart...

About Fund

-

-

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Moderate Risk

100

7854.05

0.56

19.3282

June 23, 2017

0

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

6.9 %

7.86 %

5.82 %

14.01 %

19.35 %

7.4 %

Devang Shah

B.Com., A.C.A.

Fund Manager - Fixed Income, Axis Asset Management Company Ltd. (October 16, 2012 till date). Fund Manager, ICICI Prudential Asset Management Company Limited (April 2008 - October 2012). Analyst, Deutsche Asset Management (India) Pvt. Ltd. (2006-2008). Assistant Manager, Pricewaterhouse Coopers (2004-2006).

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right